# Sientra acquires OPUS breast implant manufacturing operation from Lubrizol

Sientra acquired the dedicated FDA-approved silicone breast implant manufacturing operation in Franklin, Wisconsin from Lubrizol Life Science, including a turnkey facility in commercial scale-up.

- Type: Acquisition
- Announced: 2019-11-07
- Where: Franklin, Wisconsin, United States
- Status: completed
- Products: silicone breast implants
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Sientra](https://endata.com/companies/43180.md) (acquirer)
- [Lubrizol Life Science](https://endata.com/companies/43181.md) (target)

## Sources

- [biospace.com](https://www.biospace.com/sientra-announces-acquisition-of-the-independently-operated-opus-breast-implant-manufacturing-operation-from-lubrizol-life-science), 2019-11-07: "This acquisition advances our strategic goal of becoming the leading provider of breast products in the worldwide breast augmentation and reconstruction market."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.